Article: L1000 connectivity map interrogation identifies candidate drugs for repurposing as SARS-CoV-2 antiviral therapies.
Computational and structural biotechnology journal
2020 Volume 18, Page(s) 3947–3949
Abstract: Adaptive clinical trials are underway to determine the efficacy of potential therapies for COVID-19, with flexibility to include emerging therapies if there is sufficient preclinical evidence for their potential utility. ...
Abstract | Adaptive clinical trials are underway to determine the efficacy of potential therapies for COVID-19, with flexibility to include emerging therapies if there is sufficient preclinical evidence for their potential utility. |
---|---|
Language | English |
Publishing date | 2020-12-06 |
Publishing country | Netherlands |
Document type | Journal Article |
ZDB-ID | 2694435-2 |
ISSN | 2001-0370 |
ISSN | 2001-0370 |
DOI | 10.1016/j.csbj.2020.11.054 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.